These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4053531)

  • 1. [A two-center study on the effects of silymarin in pregnant women and adult patients with so-called minor hepatic insufficiency].
    Giannola C; Buogo F; Forestiere G; Scaffidi L; Ferrigno V; Scaffidi A
    Clin Ter; 1985 Jul; 114(2):129-35. PubMed ID: 4053531
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the therapeutic effects of silymarin].
    Margaroli P; Rossi M; Arcabasso GD; Cosini I; Malacrida C
    Clin Ter; 1980 Dec; 95(6):663-72. PubMed ID: 7214856
    [No Abstract]   [Full Text] [Related]  

  • 3. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 4. [Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model].
    Martines G; Piva M; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1979; 136(3):443-54. PubMed ID: 549550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of silymarin in intrahepatic cholestasis of pregnancy (preliminary communication)].
    Hernández R; Nazar E
    Rev Chil Obstet Ginecol; 1982; 47(1):22-9. PubMed ID: 6927150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic impairment of the hepatocyte in pregnancy: prevention and therapy with a membrane-stabilizing drug].
    Maneschi M; Tiberio C; Cittadini E
    Clin Ter; 1981 Jun; 97(6):625-30. PubMed ID: 6268349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of silymarin in the treatment of alcoholic hepatic steatosis].
    Canini F; Bartolucci L; Cristallini E; Gradoli C; Rossi A; Ribacchi R; Valori C
    Clin Ter; 1985 Aug; 114(4):307-14. PubMed ID: 4053546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency].
    Krylov AA
    Vrach Delo; 1984 Mar; (3):22-3. PubMed ID: 6719894
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A
    Clin Ter; 1981 Oct; 99(2):149-53. PubMed ID: 7318368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silymarin treatment of alcoholic liver disease].
    Orv Hetil; 1990 Jul; 131(29):1607-9. PubMed ID: 2392321
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxic occupational liver diseases. Therapeutic effects of silymarin].
    Boari C; Montanari FM; Galletti GP; Rizzoli D; Baldi E; Caudarella R; Gennari P
    Minerva Med; 1981 Oct; 72(40):2679-88. PubMed ID: 7290471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.